Tower Research Capital LLC (TRC) - ALPINE IMMUNE SCIENCES INC ownership

ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 70 filers reported holding ALPINE IMMUNE SCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ALPINE IMMUNE SCIENCES INC
ValueSharesWeighting
Q3 2023$12,286
+15.7%
1,073
+3.9%
0.00%
Q2 2023$10,619
+88391.7%
1,033
-31.1%
0.00%
Q1 2023$12
+50.0%
1,499
+46.8%
0.00%
Q4 2022$8
-99.9%
1,021
-36.3%
0.00%
Q3 2022$12,000
-93.3%
1,604
-92.4%
0.00%
-100.0%
Q2 2022$180,000
+900.0%
21,209
+958.3%
0.00%
Q1 2022$18,000
+63.6%
2,004
+148.9%
0.00%
Q4 2021$11,000
-47.6%
805
-59.5%
0.00%
-100.0%
Q3 2021$21,000
+200.0%
1,988
+178.4%
0.00%
Q2 2021$7,000
-30.0%
714
-28.2%
0.00%
Q1 2021$10,000
+150.0%
995
+243.1%
0.00%
Q4 2020$4,000
-96.7%
290
-97.9%
0.00%
-100.0%
Q3 2020$120,000
+5900.0%
13,645
+7609.0%
0.00%
Q2 2020$2,000177
+98.9%
0.00%
Q3 2019$0
-100.0%
89
-85.9%
0.00%
Q1 2019$4,000
-63.6%
633
-78.9%
0.00%
-100.0%
Q4 2018$11,000
+37.5%
2,995
+138.6%
0.00%0.0%
Q3 2018$8,000
-20.0%
1,255
-6.1%
0.00%0.0%
Q2 2018$10,000
+900.0%
1,337
+1292.7%
0.00%
Q1 2018$1,000
-90.0%
96
-89.2%
0.00%
-100.0%
Q4 2017$10,0008850.00%
Other shareholders
ALPINE IMMUNE SCIENCES INC shareholders Q3 2022
NameSharesValueWeighting ↓
Decheng Capital Management III (Cayman), LLC 6,708,288$76,809,89825.63%
Lynx1 Capital Management LP 2,404,614$27,532,83018.21%
GREAT POINT PARTNERS LLC 3,078,633$35,250,3486.42%
Ghost Tree Capital, LLC 664,132$7,604,3112.50%
Frazier Life Sciences Management, L.P. 2,985,757$34,186,9182.27%
Paradigm Biocapital Advisors LP 2,421,743$27,728,9571.88%
COMMODORE CAPITAL LP 1,325,000$15,171,2501.77%
Nan Fung Group Holdings Ltd 182,280$2,087,1061.69%
Omega Fund Management, LLC 153,700$1,759,8651.62%
Octagon Capital Advisors LP 750,000$8,587,5001.32%
View complete list of ALPINE IMMUNE SCIENCES INC shareholders